A transgenic mouse line expressing only 15% of the normal amount of VMAT2 closely mimics human PD characteristics, including deficits in l-DOPA-responsive motor activity and full-scale nonmotor symptoms [35]. The gene discussed is SLC18A2; the disease is Parkinson disease.